Vigamox 5 ml

Vigamox 5 ml is a sterile ophthalmic solution containing moxifloxacin 0.5% w/v, a fluoroquinolone antibacterial agent for topical ocular use. Prescribed primarily for bacterial conjunctivitis, Vigamox offers broad-spectrum bactericidal activity against many common ocular pathogens and is available in multi- or single-dose containers.

Key Features

About Vigamox 5 ml
Drug Class	Ophthalmic anti-infective
Subclass	Fluoroquinolone

Product Details
Composition	Active ingredient: Moxifloxacin 0.5% (5 mg/ml) Inactive ingredients: Boric acid Purified water Hydrochloric acid/Sodium chloride Sodium chloride
Packaging Type	Bottle
Pack Size	5 ml
Dosage	1–2 drops in the affected eye, three times a day or as directed by your doctor
Therapeutic class	Antibiotic
Action Class	Bactericidal
Chemical class	Fluoroquinolone antibiotic
Manufacturer	Alcon Laboratories (India) Pvt. Ltd.
Shelf Life	2-3 years from manufacturing date
Usages	Bacterial conjunctivitis and ocular infections caused by susceptible bacteria
Country of Origin	India
Storage	Store at room temperature (25–36°C), away from moisture and direct sunlight

How Vigamox (moxifloxacin) Works

Moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV—enzymes critical for DNA replication in bacteria—resulting in rapid bacterial cell death. The ophthalmic formulation achieves high concentrations directly at the infection site with minimal systemic exposure.

Indications / Uses

• Acute bacterial conjunctivitis (pink eye): Treatment of conjunctivitis caused by susceptible bacteria such as Staphylococcus spp., Streptococcus pneumoniae, Haemophilus influenzae, and others.

Not effective against viral or fungal eye infections; use only for confirmed/suspected bacterial cases under prescription.

Dosage & How to Use

• Typical dose: One drop in affected eye(s) three times daily for 7 days (may vary: 5–7 days per local guidance).
• Post-op/allergy: Surgical dosing as per protocol.
• Technique: Wash hands, tilt head, instill drop in lower lid pocket, avoid touching dropper tip to eye/surfaces. Wait 5 minutes between different eye meds.
• Contact lenses: Remove before use; only reinsert when cleared by clinician and ocular surface is healed.

Expected Benefits

• Rapid relief of symptoms, usually within 48–72 hours
• Convenient three-times-daily dosing
• Broad spectrum against common ocular bacteria

Side Effects

• Transient burning or stinging after instillation
• Eye irritation, redness, itching, foreign body sensation
• Increased tearing or discharge
• Rare: corneal disorders, keratitis, decreased vision, hypersensitivity reactions (seek urgent care for severe allergy symptoms)

Interactions & Important Clinical Notes

• Wait 5 minutes between Vigamox and other eye drops
• Review potential quinolone allergy before use
• Use antibiotics judiciously to prevent resistance

Pharmacokinetics

High local (ocular) concentrations, rapid penetration into eye tissues; minimal systemic absorption. Details in professional monographs.

Precautions & Who Should Be Careful

• Contraindicated in patients with known allergy to moxifloxacin/quinolones/excipients
• Use pediatric dosing as per local guidelines
• Prolonged use may cause superinfection (fungal overgrowth)
• Discuss pregnancy/breastfeeding risk with doctor

Storage & Handling

• Store as per label (typically room temperature); avoid contamination of dropper tip; discard single-use vials after opening
• Keep out of reach of children

Practical Tips & Realistic Expectations

• Complete the full prescribed course for best results
• Minimize contamination when instilling drops
• Seek help if pain, vision loss, or severe allergy signs occur

Comparison with Alternatives

Other topical antibiotics include older fluoroquinolones, aminoglycosides, and macrolides. Dosing convenience (e.g., Moxeza twice daily) and susceptibility guide selection. Consult with prescriber/pharmacist for best choice.

Conclusion

Vigamox 5 ml is a widely used topical antibiotic for bacterial conjunctivitis, providing fast and effective relief when used as prescribed. Most side effects are mild and local; prolonged use or allergy should be discussed with a prescriber.

References

• https://www.ncbi.nlm.nih.gov/books/NBK599511/
• https://pubchem.ncbi.nlm.nih.gov/compound/Moxifloxacin-Hydrochloride

FAQ’s

[sp_easyaccordion id=”35079″]